A longitudinal One Health genomic survey of Clostridium perfringens reveals extensive genomic diversity and novelty, frequent plasmid carriage, and source-structured resistome signatures
<div>Objectives: To define the population structure and clinically relevant genomic traits of <i>Clostridium perfringens </i>within a One Health framework across human, animal, and food sources.</div><div/><div><br/>Methods: We analyzed whole-genome sequences from 100 isolates collected in Costa Rica from humans, animals, and food between 1997 and 2022 and assessed phylogenetic relationships, strain diversity, pangenome structure, toxin gene repertoires, antimicrobial resistance (AMR) genes, and signatures of plasmid mobility, including <i>Tcp/Pcp</i> genes.</div><div/><div><br/>Results: The collection revealed a wide range of diversity and novelty, with Costa Rican isolates broadly distributed across a globally diverse context, alongside several local monophyletic clusters and cross-source mixing within the Costa Rican subset. No identical sequence types were shared across sources, but we identified an animal–human single-locus variant pair spanning ≥13 years. Pangenome analyses supported an open genome with a small core (16–17% of gene families). Virulence gene profiling showed universal <i>plc</i>, frequent <i>pfo</i>, and <i>cpb2</i> enriched in humans. We detected 12 acquired antibiotic resistance genes. Although the overall burden of AMR genes did not vary by source, there was a notable enrichment of tetracycline-associated genes in humans and aminoglycoside-associated genes in animals. Contigs of presumptive plasmid origin were observed in 46–71% of isolates, with widespread <i>Tcp </i>(55–71%) and <i>Pcp</i> (27–50%) markers and recurring antibiotic resistance genes genomic neighborhoods, consistent with lateral gene transfer.</div><div/><div><br/>Conclusion: Costa Rican C. <i>perfringens</i> exhibit high genomic diversity, source-structured AMR composition, and frequent mobility potential, supporting One Health genomic surveillance to refine AMR risk assessment and food/veterinary/public health monitoring.</div><div/>
Authors
- Elias Barquero-Calvo
- Lindsay J. Hall (ORCID: https://orcid.org/0000-0001-8938-5709)
- Raymond Kiu (ORCID: https://orcid.org/0000-0002-4483-1215)
- Amber D. Kimble (ORCID: https://orcid.org/0000-0001-6785-1596)
- César Rodríguez
- Daniela Aguilar
Institutions
- University of East Anglia (GB)
- Universidad Nacional (CR)
- Quadram Institute (GB)
- Universidad de Costa Rica (CR)
- Mount Sinai Hospital (US)
- University of Birmingham (GB)
Publication Details
- Journal
- IJID One Health
- Published
- 2026-04-06
- DOI
- https://doi.org/10.1016/j.ijidoh.2026.100123
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust
- University of Birmingham
- Biotechnology and Biological Sciences Research Council